1Division of Nephrology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea
2Division of Nephrology, Department of Internal Medicine, CHA Gumi Medical Center, CHA University, Gumi, Korea
Copyright © 2021 Yeungnam University College of Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of interest
No potential conflict of interest relevant to this article was reported.
Funding
This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT) (2017R1C1B5077075), and the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning. The founder had no role in study design, collection, analysis, and interpretation of data, writing the report, and the decision to submit the report for publication.
Author contributions
Conceptualization and Funding acquisition: SHK; Data acquisition, SHK, JYD, JCK; Formal analysis and Data interpretation: SHK, JCK; Writing-original draft: SHK, JCK; Writing-review & editing: all authors.
Characteristic | Non-D (n=1,312) | Mild-D (n=163) | MS-D (n=140) | p-valuea) |
---|---|---|---|---|
Age (yr) | 55.0±12.7 | 57.9±13.5 | 61.1±13.1b),c) | <0.001 |
Male sex | 736 (56.1) | 92 (56.4) | 75 (53.2) | 0.795 |
Body mass index (kg/m2) | 22.4±3.2 | 22.3±3.1 | 22.4±3.4 | 0.967 |
Diabetes mellitus | 496 (37.8) | 66 (40.5) | 77 (54.6) | 0.001 |
Coronary artery disease | 193 (14.7) | 25 (15.3) | 36 (25.5) | 0.004 |
Cerebrovascular disease | 103 (7.9) | 19 (11.7) | 22 (15.6) | 0.004 |
Dialysis vintage (yr) | 5.1±4.4 | 5.4±4.5 | 5.0±4.9 | 0.729 |
Education level | 0.579 | |||
≤6th grade | 278 (21.2) | 41 (25.2) | 34 (24.3) | |
7th–12th grade | 259 (19.7) | 35 (21.5) | 26 (18.6) | |
>12th grade | 775 (59.1) | 87 (53.4) | 80 (57.1) | |
Hemoglobin (mg/dL) | 10.5±0.9 | 10.4±0.9 | 10.4±1.1 | 0.546 |
Serum albumin (mg/dL) | 3.9±0.4 | 3.8±0.4 | 3.8±0.4b) | <0.001 |
BUN (mg/dL) | 60.6±15.0 | 57.6±15.6 | 57.5±14.1 | 0.007 |
Creatinine (mg/dL) | 10.6±3.0 | 10.1±2.9 | 9.6±3.0b) | <0.001 |
Calcium (mg/dL) | 8.72±0.83 | 8.64±0.76 | 8.58±0.84 | 0.085 |
Phosphorus (mg/dL) | 5.37±1.36 | 5.06±1.35 | 4.79±1.18b),c) | <0.001 |
Total cholesterol (mg/dL) | 153.5±36.7 | 156.1±38.6 | 156.2±40.9 | 0.551 |
i-PTH (pg/mL) | 283.8±345.1 | 277.5±378.2 | 216.8±254.9 | 0.087 |
hs-CRP (mg/dL) | 0.68±1.63 | 0.76±1.93 | 0.62±1.29 | 0.837 |
Dialysis modality (HD) | 1,053 (80.3) | 103 (63.2) | 94 (66.7) | <0.001 |
Follow-up (day) | 487±114 | 463±125b) | 487±82c) | 0.046 |
Values are presented as mean±standard deviation for continuous variables and number (%) for categorical variables.
Non-D, non-disabled group; Mild-D, mildly disabled group; MS-D, moderate to severely disabled group; BUN, blood urea nitrogen; i-PTH, intact-parathyroid hormone; hs-CRP, high-sensitivity C-reactive protein; HD, hemodialysis.
a) p-values were tested by using one-way analysis of variance, followed by a post-hoc Tukey comparison, for continuous variables, and Pearson chi-square test for categorical variables.
b) p<0.05 vs. the Non-D group.
c) p<0.05 vs. the Mild-D group. There was no significant difference in variables between groups without superscripts, such as b) or c).
Scale |
Univariate (mean±SD) |
Multivariate (mean±SE) |
||||||
---|---|---|---|---|---|---|---|---|
Non-D | Mild-D | MS-D | p-value | Non-D | Mild-D | MS-D | p-value | |
SF-36 scale | ||||||||
PF | 78.4±20.0 | 62.2±26.3a) | 49.2±31.9a,b) | <0.001 | 76.6±0.8 | 64.4±1.8a) | 51.4±2.1a,b) | <0.001 |
RP | 69.5±39.6 | 49.3±41.8a) | 38.7±43.9a,b) | <0.001 | 69.9±1.5 | 55.4±3.7a) | 35.4±4.2a,b) | <0.001 |
BP | 80.1±24.1 | 70.5±27.3a) | 61.4±28.2a,b) | <0.001 | 79.8±0.9 | 74.2±2.3a) | 59.7±2.6a,b) | <0.001 |
GH | 46.0±22.3 | 39.2±21.9a) | 35.1±21.9a) | <0.001 | 46.0±0.9 | 40.8±2.1a) | 33.3±2.4a) | <0.001 |
VT | 46.5±20.8 | 39.4±20.6a) | 34.6±22.2a,b) | <0.001 | 46.6±0.8 | 41.6±2.0a) | 34.7±2.2a) | <0.001 |
SF | 78.1±26.7 | 66.6±27.8a) | 60.9±31.6a) | <0.001 | 77.9±1.1 | 67.8±2.6a) | 59.6±3.0a) | <0.001 |
RE | 75.1±39.6 | 55.3±44.6a) | 49.2±45.9a) | <0.001 | 76.6±1.6 | 63.2±3.8a) | 41.9±4.3a,b) | <0.001 |
MH | 60.8±19.7 | 52.7±20.0a) | 48.3±22.7a) | <0.001 | 62.0±0.8 | 55.0±1.9a) | 46.7±2.2a,b) | <0.001 |
OHR | 39.0±25.4 | 33.7±28.9 | 27.8±25.7a,b) | <0.001 | 37.4±1.0 | 34.9±2.4 | 27.4±2.7a,b) | 0.003 |
PCS | 64.1±18.9 | 52.1±21.1a) | 43.8±23.2a,b) | <0.001 | 63.8±0.7 | 55.3±1.8a) | 42.9±2.0a,b) | <0.001 |
MCS | 61.3±19.5 | 50.7±20.3a) | 45.6±22.5a,b) | <0.001 | 61.8±0.8 | 53.7±1.8a) | 43.2±2.1a,b) | <0.001 |
KD-specific scale | ||||||||
SP | 81.9±13.5 | 74.5±17.1a) | 70.6±18.9a,b) | <0.001 | 82.4±0.6 | 77.3±1.3a) | 69.3±1.5a,b) | <0.001 |
EKD | 75.2±17.9 | 66.3±20.8a) | 60.6±22.3a,b) | <0.001 | 76.6±0.7 | 67.6±1.7a) | 57.6±1.9a,b) | <0.001 |
BKD | 36.8±26.2 | 27.4±25.3a) | 27.7±26.6a) | <0.001 | 37.2±1.0 | 27.3±2.4a) | 25.2±2.8a) | <0.001 |
WS | 29.9±37.1 | 21.2±32.3a) | 16.7±29.1a) | <0.001 | 29.3±1.3 | 21.3±3.3a) | 23.9±3.8 | 0.049 |
CF | 88.1±15.2 | 80.3±20.9a) | 73.2±24.3a,b) | <0.001 | 88.9±0.6 | 82.7±1.5a) | 70.7±1.8a,b) | <0.001 |
QSI | 77.5±20.6 | 69.2±21.9a) | 62.7±26.3a,b) | <0.001 | 77.0±0.8 | 69.8±2.0a) | 58.6±2.3a,b) | <0.001 |
SeF | 78.1±25.9 | 69.3±29.9 | 77.2±24.0 | 0.230 | 77.7±2.2 | 69.0±6.1 | 88.5±8.3 | 0.155 |
Sleep | 65.6±21.0 | 57.4±21.6a) | 56.7±21.0a) | <0.001 | 66.7±0.8 | 56.8±1.9a) | 55.6±2.2a) | <0.001 |
SS | 68.9±26.9 | 59.2±27.2a) | 66.7±26.3b) | <0.001 | 67.6±1.1 | 61.5±2.6 | 65.5±2.9 | 0.084 |
PS | 66.6±22.7 | 61.7±24.4 | 63.1±21.5 | 0.013 | 66.5±0.9 | 60.3±2.1 | 63.2±2.4 | 0.019 |
DSE | 86.2±18.1 | 84.7±20.5 | 87.9±18.5 | 0.310 | 88.3±0.7 | 85.6±1.6 | 86.6±1.8 | 0.260 |
p-values were determined by using Student’s t-test for univariate analysis and analysis of covariance for multivariate analysis. The multivariate analysis was adjusted for age, sex, body mass index, dialysis modality, diabetes mellitus, cerebrovascular disease, coronary artery disease, dialysis vintage, education level, levels of hemoglobin, serum albumin, blood urea nitrogen, serum creatinine, calcium, phosphorus, total cholesterol, intact-parathyroid hormone, and high-sensitivity C-reactive protein.
SD, standard deviation; SE, standard error; Non-D, non-disabled group; Mild-D, mildly disabled group; MS-D, moderate to severely disabled group; SF-36, 36-Item Short Form Health Survey; PF, physical functioning; RP, role limitations due to physical health problems; BP, body pain; GH, general health; VT, vitality; SF, social functioning; RE, role limitations due to emotional problems; MH, mental health; OHR, overall health rating; PCS, physical component scale; MCS, mental component scale; KD, kidney disease; SP, symptom/problems; EKD, effects of kidney disease; BKD, burden of kidney disease; WS, work status; CF, cognitive function; QSI, quality of social interaction; SeF, sexual function; SS, social support; PS, patient satisfaction; DSE, dialysis staff encouragement.
a) p<0.05 vs. the Non-D group.
b) p<0.05 vs. the Mild-D group. There was no significant difference in variables between groups without superscripts, such as a) or b).
Multivariate analysis was adjusted for age, sex, body mass index, dialysis modality, diabetes mellitus, cerebrovascular disease, coronary artery disease, dialysis vintage, education level, and levels of hemoglobin, serum albumin, blood urea nitrogen, serum creatinine, calcium, phosphorus, total cholesterol, intact-parathyroid hormone, and high-sensitivity C-reactive protein.
CI, confidence interval; Non-D, non-disabled group; Mild-D, mildly disabled group; MS-D, moderate to severely disabled group; ref, reference; HFS, hospitalization-free survival.
Characteristic | Non-D (n=1,312) | Mild-D (n=163) | MS-D (n=140) | p-value |
---|---|---|---|---|
Age (yr) | 55.0±12.7 | 57.9±13.5 | 61.1±13.1 |
<0.001 |
Male sex | 736 (56.1) | 92 (56.4) | 75 (53.2) | 0.795 |
Body mass index (kg/m2) | 22.4±3.2 | 22.3±3.1 | 22.4±3.4 | 0.967 |
Diabetes mellitus | 496 (37.8) | 66 (40.5) | 77 (54.6) | 0.001 |
Coronary artery disease | 193 (14.7) | 25 (15.3) | 36 (25.5) | 0.004 |
Cerebrovascular disease | 103 (7.9) | 19 (11.7) | 22 (15.6) | 0.004 |
Dialysis vintage (yr) | 5.1±4.4 | 5.4±4.5 | 5.0±4.9 | 0.729 |
Education level | 0.579 | |||
≤6th grade | 278 (21.2) | 41 (25.2) | 34 (24.3) | |
7th–12th grade | 259 (19.7) | 35 (21.5) | 26 (18.6) | |
>12th grade | 775 (59.1) | 87 (53.4) | 80 (57.1) | |
Hemoglobin (mg/dL) | 10.5±0.9 | 10.4±0.9 | 10.4±1.1 | 0.546 |
Serum albumin (mg/dL) | 3.9±0.4 | 3.8±0.4 | 3.8±0.4 |
<0.001 |
BUN (mg/dL) | 60.6±15.0 | 57.6±15.6 | 57.5±14.1 | 0.007 |
Creatinine (mg/dL) | 10.6±3.0 | 10.1±2.9 | 9.6±3.0 |
<0.001 |
Calcium (mg/dL) | 8.72±0.83 | 8.64±0.76 | 8.58±0.84 | 0.085 |
Phosphorus (mg/dL) | 5.37±1.36 | 5.06±1.35 | 4.79±1.18 |
<0.001 |
Total cholesterol (mg/dL) | 153.5±36.7 | 156.1±38.6 | 156.2±40.9 | 0.551 |
i-PTH (pg/mL) | 283.8±345.1 | 277.5±378.2 | 216.8±254.9 | 0.087 |
hs-CRP (mg/dL) | 0.68±1.63 | 0.76±1.93 | 0.62±1.29 | 0.837 |
Dialysis modality (HD) | 1,053 (80.3) | 103 (63.2) | 94 (66.7) | <0.001 |
Follow-up (day) | 487±114 | 463±125 |
487±82 |
0.046 |
Scale | Univariate (mean±SD) |
Multivariate (mean±SE) |
||||||
---|---|---|---|---|---|---|---|---|
Non-D | Mild-D | MS-D | p-value | Non-D | Mild-D | MS-D | p-value | |
SF-36 scale | ||||||||
PF | 78.4±20.0 | 62.2±26.3 |
49.2±31.9 |
<0.001 | 76.6±0.8 | 64.4±1.8 |
51.4±2.1 |
<0.001 |
RP | 69.5±39.6 | 49.3±41.8 |
38.7±43.9 |
<0.001 | 69.9±1.5 | 55.4±3.7 |
35.4±4.2 |
<0.001 |
BP | 80.1±24.1 | 70.5±27.3 |
61.4±28.2 |
<0.001 | 79.8±0.9 | 74.2±2.3 |
59.7±2.6 |
<0.001 |
GH | 46.0±22.3 | 39.2±21.9 |
35.1±21.9 |
<0.001 | 46.0±0.9 | 40.8±2.1 |
33.3±2.4 |
<0.001 |
VT | 46.5±20.8 | 39.4±20.6 |
34.6±22.2 |
<0.001 | 46.6±0.8 | 41.6±2.0 |
34.7±2.2 |
<0.001 |
SF | 78.1±26.7 | 66.6±27.8 |
60.9±31.6 |
<0.001 | 77.9±1.1 | 67.8±2.6 |
59.6±3.0 |
<0.001 |
RE | 75.1±39.6 | 55.3±44.6 |
49.2±45.9 |
<0.001 | 76.6±1.6 | 63.2±3.8 |
41.9±4.3 |
<0.001 |
MH | 60.8±19.7 | 52.7±20.0 |
48.3±22.7 |
<0.001 | 62.0±0.8 | 55.0±1.9 |
46.7±2.2 |
<0.001 |
OHR | 39.0±25.4 | 33.7±28.9 | 27.8±25.7 |
<0.001 | 37.4±1.0 | 34.9±2.4 | 27.4±2.7 |
0.003 |
PCS | 64.1±18.9 | 52.1±21.1 |
43.8±23.2 |
<0.001 | 63.8±0.7 | 55.3±1.8 |
42.9±2.0 |
<0.001 |
MCS | 61.3±19.5 | 50.7±20.3 |
45.6±22.5 |
<0.001 | 61.8±0.8 | 53.7±1.8 |
43.2±2.1 |
<0.001 |
KD-specific scale | ||||||||
SP | 81.9±13.5 | 74.5±17.1 |
70.6±18.9 |
<0.001 | 82.4±0.6 | 77.3±1.3 |
69.3±1.5 |
<0.001 |
EKD | 75.2±17.9 | 66.3±20.8 |
60.6±22.3 |
<0.001 | 76.6±0.7 | 67.6±1.7 |
57.6±1.9 |
<0.001 |
BKD | 36.8±26.2 | 27.4±25.3 |
27.7±26.6 |
<0.001 | 37.2±1.0 | 27.3±2.4 |
25.2±2.8 |
<0.001 |
WS | 29.9±37.1 | 21.2±32.3 |
16.7±29.1 |
<0.001 | 29.3±1.3 | 21.3±3.3 |
23.9±3.8 | 0.049 |
CF | 88.1±15.2 | 80.3±20.9 |
73.2±24.3 |
<0.001 | 88.9±0.6 | 82.7±1.5 |
70.7±1.8 |
<0.001 |
QSI | 77.5±20.6 | 69.2±21.9 |
62.7±26.3 |
<0.001 | 77.0±0.8 | 69.8±2.0 |
58.6±2.3 |
<0.001 |
SeF | 78.1±25.9 | 69.3±29.9 | 77.2±24.0 | 0.230 | 77.7±2.2 | 69.0±6.1 | 88.5±8.3 | 0.155 |
Sleep | 65.6±21.0 | 57.4±21.6 |
56.7±21.0 |
<0.001 | 66.7±0.8 | 56.8±1.9 |
55.6±2.2 |
<0.001 |
SS | 68.9±26.9 | 59.2±27.2 |
66.7±26.3 |
<0.001 | 67.6±1.1 | 61.5±2.6 | 65.5±2.9 | 0.084 |
PS | 66.6±22.7 | 61.7±24.4 | 63.1±21.5 | 0.013 | 66.5±0.9 | 60.3±2.1 | 63.2±2.4 | 0.019 |
DSE | 86.2±18.1 | 84.7±20.5 | 87.9±18.5 | 0.310 | 88.3±0.7 | 85.6±1.6 | 86.6±1.8 | 0.260 |
Variable | Univariate |
Multivariate |
||
---|---|---|---|---|
Hazard ratio (95% CI) | p-value | Hazard ratio (95% CI) | p-value | |
Patient survival | ||||
Non-D (ref) | - | - | - | - |
Mild-D | 2.32 (1.34–4.03) | 0.003 | 2.15 (1.08–4.30) | 0.030 |
MS-D | 1.73 (0.91–3.29) | 0.095 | 1.26 (0.55–2.87) | 0.583 |
Mild-D (ref) | - | - | - | - |
MS-D | 0.74 (0.34–1.59) | 0.436 | 0.58 (0.21–1.56) | 0.277 |
First HFS | ||||
Non-D (ref) | - | - | - | - |
Mild-D | 1.34 (1.04–1.72) | 0.025 | 1.33 (0.98–1.81) | 0.064 |
MS-D | 1.52 (1.18–1.97) | 0.001 | 1.23 (0.89–1.71) | 0.210 |
Mild-D (ref) | - | - | - | - |
MS-D | 1.14 (0.81–1.60) | 0.445 | 0.80 (0.52–1.23) | 0.303 |
Values are presented as mean±standard deviation for continuous variables and number (%) for categorical variables. Non-D, non-disabled group; Mild-D, mildly disabled group; MS-D, moderate to severely disabled group; BUN, blood urea nitrogen; i-PTH, intact-parathyroid hormone; hs-CRP, high-sensitivity C-reactive protein; HD, hemodialysis.
SD, standard deviation; SE, standard error; Non-D, non-disabled group; Mild-D, mildly disabled group; MS-D, moderate to severely disabled group; SF-36, 36-Item Short Form Health Survey; PF, physical functioning; RP, role limitations due to physical health problems; BP, body pain; GH, general health; VT, vitality; SF, social functioning; RE, role limitations due to emotional problems; MH, mental health; OHR, overall health rating; PCS, physical component scale; MCS, mental component scale; KD, kidney disease; SP, symptom/problems; EKD, effects of kidney disease; BKD, burden of kidney disease; WS, work status; CF, cognitive function; QSI, quality of social interaction; SeF, sexual function; SS, social support; PS, patient satisfaction; DSE, dialysis staff encouragement.
Multivariate analysis was adjusted for age, sex, body mass index, dialysis modality, diabetes mellitus, cerebrovascular disease, coronary artery disease, dialysis vintage, education level, and levels of hemoglobin, serum albumin, blood urea nitrogen, serum creatinine, calcium, phosphorus, total cholesterol, intact-parathyroid hormone, and high-sensitivity C-reactive protein. CI, confidence interval; Non-D, non-disabled group; Mild-D, mildly disabled group; MS-D, moderate to severely disabled group; ref, reference; HFS, hospitalization-free survival.